Mesoblast reported an initial statement of beneficial ownership by director George Gregory. The filing listed indirect warrants for 6.83 million ordinary shares with an exercise price of USD 2.86. It also listed direct warrants for 200,000 ADS with an exercise price of USD 9.06. The filing also included direct options covering 66,667 ordinary shares with an exercise price of USD 1.72.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001999371-26-006045), on March 16, 2026, and is solely responsible for the information contained therein.